Opexa Therapeutics, Inc. (OPXA) Reports Q3 Loss of $0.10
Tweet
Share
E-mailGet Alerts OPXA Hot Sheet
Price: $0.97 --0%
Financial Fact:
Basic and diluted loss per share: -0.28
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Basic and diluted loss per share: -0.28
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Opexa Therapeutics, Inc. (NASDAQ: OPXA) reported Q3 EPS of ($0.10), versus ($0.06) reported last year. Revenue for the quarter came in at $0 versus the consensus estimate of $0 .
For earnings history and earnings-related data on Opexa Therapeutics, Inc. (OPXA) click here.
For earnings history and earnings-related data on Opexa Therapeutics, Inc. (OPXA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
- UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
